smartcybers786@gmail.com 
#relief #pain #Political #Economy
Or dozens of cancer patients at AGA Khan University Hospital, the pain is no longer part of their disease. It has become a cruel, relentless partner. The cause is the deficiency of injection morphine.
Hospital pain management experts say injection morphine requires a large number of many sick patients, including children and the elderly. By mid -August, stocks were over.
Now, the hospital can only present the morphine in the form of a capsule, which slowly releases and takes time to work, very slow for people with severe problems. Morphine syrup is also not available. Doctors say that when a child is screaming in harassment or an elderly patient cannot swallow, the capsule is of no use.
The situation is slightly better at Shukat Khanum Memorial Cancer Hospital in Lahore and Indus Hospital in Karachi. These facilities still have injection and oral morphine, but they want permanent access throughout the year, not only the annual allocation that can end mid -year. They also emphasize the need for a savior, a phenotary, a phenomenon.
Experts say that phenynell is 100 times more powerful than morphine. It often comes in the form of a patch, which is very important for patients who cannot swallow or tolerate morphine. In Pakistan, these patches are not available. Phenynell injections are imported but only used for anesthesia and are not stocking in large quantities to get available for cancer pain.
Pakistan’s Drug Regulatory Authority has defended a limited supply, saying that the country’s applications to the International Drug Control Board are based on hospital requests and past use. Applications run by provincial governments, which inspect the application facilities before sending applications to the Ministry of Drug Control, which has no objection certificate for an objection certificate.
In Islamabad, the hospital can apply directly to the drop, which then sends forward the paperwork for the NOC after inspection. Before considering requests, the stock level should fall from 50 to 80 percent. Drug companies will also have to apply an annual to allow control of controlled medicines. Once the stock is almost over, hospitals will have to look for a fresh NOC to accept new delivery.
Pakistan receives about 185,000 new cases of cancer every year, with more than 118,000 deaths. At any time, hundreds of thousands of patients need any form of pain medications. A significant number of stronger opioids like Morphine or Phantinel are needed.
The anti -narcotics force oversees the drip, which includes another layer of decision -making. Hospitals say the problem is hesitant to start the process for fear of getting involved in red tape.
Pakistan receives about 185,000 new cases of cancer every year, with more than 118,000 deaths. At any time, hundreds of thousands of patients need some form of pain medications. A significant number of stronger opioids like Morphine or Phantinel are needed. Of these, 17 -year -old Ayman, who is fighting osteosaroma, has a bone cancer that has lost his muscles and depends on others. Last month, Islamabad’s planned journey had to be canceled because its pain was severe.
The request of his family is often not answered for the Morphine. They sometimes succeed in getting small quantities from hospitals. She considers her pain unbearable. Its trial has been worsened by the knowledge that a drug used for more than two centuries is beyond the trafficking of the morphine.
The World Health Organization has a list of oral morphine, morphine injections and phenothenary patch in essential medicines to get rid of cancer pain. It calls for a balance between medical use and availability to prevent abuse. However, in Pakistan, many hospitals do not apply for quota. Some public facilities do not apply at all.
In the absence of morphine and phenothenyl, patients are given traumadol, coden or nilbophine that are easy to achieve but noted for acute cancer pain.
Morphine is relatively cheap to produce. If there was a change in the policy, its supply could be improved at a small price. In the context of cancer maintenance, phenothenary patches are more expensive but still cheap. Doctors say the solution is to simplify hospital requests, increase maintenance flexibility, to ensure that pharmaceutical companies can maintain uninterrupted supply and reduce layers of approval that currently reduce the process.
M. Waqar Bhatti is an investigative reporter who currently covers health, science, environment and water problems for News International.
Sarah Iram Gul is a freelance journalist whose experience has been many years.
